LIPELLA PHARMACEUTICALS INC.
LIPO · OTCMCIK 1347242fmd_0TCBPZJFHVC29J6RFW8N58SCWVManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2021 to Sep 30, 2025, 16 periods
| Line item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 1 |
| Research and development | 1 | 3 | 3 | 4 |
| Operating income | (2) | (3) | (5) | (5) |
| Interest expense | 0 | 0 | 0 | – |
| Interest and investment income | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | 0 | (0) | 0 | 0 |
| Income before taxes | (2) | (3) | (5) | (5) |
| Net income | (2) | (3) | (5) | (5) |